A UK National Cancer Research Institute trial led from The University of Manchester and the Christie NHS Foundation Trust has suggested that in patients with early stage Hodgkin lymphoma the late effects of radiotherapy could be reduced by using a scan to determine those who actually need it. In a paper published in the New England Journal of Medicine , the scientists show that a positron-emission tomography scan immediately after treatment with chemotherapy can identify patients who have a very good outcome without additional radiotherapy.
http://ift.tt/1QkIdxy
No comments:
Post a Comment